Fisher Seeks Green Light to Bring MDMA into U.S. for Research
Published Date: 4/1/2026
Notice
Summary
Fisher Clinical Services, Inc. wants to become an official importer of certain controlled substances, including MDMA. People and companies involved with these drugs can share their thoughts or ask for a hearing by May 1, 2026. This move could impact how these substances are brought into the U.S., so keep an eye on the deadline if you want to speak up!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in